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ABSTRACT 
 15 
A study of the fragmentation pathways of several classes of drugs of abuse 
(cannabinoids, ketamine, amphetamine and amphetamine-type stimulants, cocaine and 
opiates) and their related substances has been made. The knowledge of the 
fragmentation is highly useful for specific fragment selection or for recognition of 
related compounds when developing MS-based analytical methods for the trace level 20 
determination of these compounds in complex matrices. In this work, accurate-mass 
spectra of selected compounds were obtained using liquid chromatography coupled to 
quadrupole time-of-flight mass spectrometry, performing both MS/MS and MS
E
 
experiments. As regards fragmentation behavior, the mass spectra of both approaches 
were quite similar, and were useful to study the fragmentation of the drugs investigated. 25 
Accurate-mass spectra of 37 drugs of abuse and related compounds, including 
metabolites and deuterated analogues, were studied in this work and structures of 
fragment ions were proposed. The accurate-mass data obtained allowed to confirm 
structures and fragmentation pathways previously proposed based on nominal mass 
measurements, although new insights and  structure proposals were achieved in some 30 
particular cases, especially for amphetamine and amphetamine-type stimulants, 11-nor-
9-carboxy-∆9-tetrahydrocannabinol (THC-COOH) and opiates.  
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1. INTRODUCTION 
 
In the recent years, there has been an increasing concern on the occurrence of 
drugs in the environment. In one of the first papers, Ternes et al. 
[1]
 reported significant 40 
concentrations of different classes of drugs in sewage and surface waters. Since then, a 
notable number of studies have been reported, and the number of articles published in 
this area is still increasing. 
[2]
 A group of drugs of particular interest are (illicit) drugs of 
abuse, which are frequently found in the aquatic environment, particularly in urban 
wastewater. Methods based on liquid chromatography-tandem mass spectrometry (LC–45 
MS/MS) using triple quadrupole (QqQ) analyzers are important for determination of 
these compounds and their metabolites. This allows the rapid and efficient simultaneous 
quantification and confirmation at low analyte concentrations, e.g. ng/L levels, in 
samples such as surface water and urban wastewater with little sample manipulation. 
[3, 
4]
 50 
Wide-scope screening of organic contaminants in environmental samples is 
gaining popularity thanks to the hyphenation of LC to high-resolution mass 
spectrometry (HR MS), e.g. orbitrap and time-of-flight (TOF) instruments. HR MS has 
strong potential for detection and identification purposes as a consequence of the full-
spectrum acquisition with satisfactory sensitivity - allowing accurate-mass 55 
measurements of the analyte molecule and/or its main fragments -, the ability of 
performing retrospective analysis without the need of additional sample injections, and 
the feasibility of investigating a large number of contaminants after MS acquisition 
using a post-target approach. 
[5]
 LC–HR MS has been successfully applied for accurate-
mass screening of (polar) target compounds and/or their metabolites, and to discover 60 
non-target contaminants. 
[6-10]
 Some papers report on the use of LC–HR MS for 
identification of illicit drugs and metabolites in surface water and wastewater. 
[11, 12]
 
Accurate-mass measurements of protonated molecules and their fragments allowed the 
reliable identification of the target compounds. 
Data obtained on the levels of drugs of abuse in urban wastewater have been 65 
used to estimate illicit drugs consumption of a certain community and to appreciate their 
potential environmental impact. 
[13-15]
 To fully understand the real impact of these 
compounds in the environment, not only parent drugs should be taken into account but 
also their metabolites. Some of them are well known to be excreted by human beings 
and might be observed in the aquatic environment. In addition, other potentially 70 
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hazardous transformation products (TPs) might be formed in the aquatic environment or 
in wastewater treatment plants (WWTPs) as well. From an analytical point of view, 
knowledge on the fragmentation of different classes of illicit drugs is of great interest, 
as the recognition of specific product ions and the application of basic fragmentation 
rules may help to elucidate “unknown” related compounds. The selection of more 75 
specific fragment ions would allow minimizing potential interferences and would be of 
great help to confirm the identity of the compounds detected in complex matrices. 
When using a QTOF instrument, application of the MS
E
 mode is feasible, i.e. 
performing simultaneous acquisition of MS spectra at low (LE) and high (HE) collision 
energy. 
[12]
 In addition, conventional MS/MS experiments can be made to obtain 80 
accurate-mass product ion spectra, which is highly useful for confirmative purposes. 
Both approaches are powerful for investigation of fragmentation of drugs of abuse and 
have been applied in this paper. 
Several papers report on fragmentation of drugs of abuse, making use of GC–
MS 
[16, 17]
 and/or LC–MS with different analyzers. Only LC–MS was taken into account 85 
in this paper, as fragmentation of molecular ions generated by electron ionization, 
typically applied in GC–MS, notably differs from fragmentation of protonated 
molecules generated by atmospheric pressure ionization typically employed in LC–MS. 
LC–MS is nowadays the technique of choice for the wide majority of drugs of abuse 
and metabolites.  90 
Mass analyzers, acquiring in nominal or accurate mass, have been used to the 
study of fragmentation of drugs of abuse. Recently, Castiglioni et al. 
[3]
 reviewed mass 
spectra and fragmentation patterns of several classes of illicit drugs. In most cases, low-
resolution MS analyzers have been applied to elucidate the most abundant fragments. 
[18-22]
 However, for more detailed fragmentation and in cases of ambiguity, HR MS or a 95 
combination of techniques (including the use of isotope labeled analogues) needs to be 
applied. 
[23-27]
 In this paper, we report a detailed study on the fragmentation of several 
classes of illicit drugs and their related substances (metabolites/degradation products) 
using accurate mass measurements provided by LC–QTOF MS. Whereas some 
information already exists in the literature, often data are yet incomplete or, in some 100 
cases, the interpretation of mass spectra might be questionable. Information provided in 
this work will be of help for future method development and data interpretation in LC–
MS based analytical methodology. 
 Page 5 of 38 
 
2. EXPERIMENTAL 
 105 
2.1. Reagents and chemicals 
Illicit drugs and metabolites studied were the following: amphetamine, 
methamphetamine, 3,4-methylenedioxyamphetamine (MDA), 3,4-
methylenedioxymethamphetamine (MDMA or ecstasy), 3,4-
methylenedioxyethylamphetamine (MDEA), R(+)-methcathinone, 1R,2S(-)ephedrine, 110 
cocaine, cocaethylene, benzoylecgonine, norbenzoylecgonine, norcocaine, ecgonine, 
ketamine, heroin, codeine, norcodeine, morphine, 6-monoacetylmorphine (6-MAM), 
normorphine and 11-nor-9-carboxy-∆9-tetrahydrocannabinol (THC-COOH). These 
compounds were purchased from Sigma–Aldrich (St. Louis, MO, USA), Cerilliant 
(Round Rock, TX, USA) and the National Measurement Institute (Pymble, Australia) as 115 
solutions in methanol (MeOH), acetonitrile or as salt. Standard stock solutions of each 
compound were prepared at 100 mg/L in MeOH or acetonitrile. 
Deuterium labeled compounds were all obtained from Cerilliant as solutions in 
MeOH or acetonitrile at a concentration of 100 mg/L: amphetamine-d6, 
methamphetamine-d5 MDA-d5, MDMA-d5, MDEA-d5, 1S,2R(+)ephedrine-d3, cocaine-120 
d3, cocaethylene-d8, benzoylecgonine-d3, ecgonine-d3, ketamine-d4, heroin-d9, codeine-
d6, morphine-d3, 6-MAM-d6 and THC-COOH-d3.  
Intermediate solutions (10 mg/L) were prepared by diluting the stock solutions 
with MeOH. All standard solutions were stored in amber glass bottles at −20 ºC. 
Working solutions of individual standards were prepared at a concentration of 100 µg/L 125 
in MeOH:water (5:95, v/v) just before MS
E
 and MS/MS experiments.  
Chemical structure, exact mass of the protonated molecule, and CAS number of 
the selected illicit drugs and their deuterated analogues are listed in Table SI 1 of 
Supporting Information (SI). 
 130 
2.2. Instrumentation 
A Waters Acquity ultra-high-performance liquid chromatography (UHPLC) 
system (Waters, Milford, MA, USA) was interfaced to a hybrid quadrupole orthogonal 
acceleration time-of-flight mass spectrometer (QTOF Premier, Waters Micromass, 
Manchester, UK) equipped with an orthogonal Z-spray electrospray ionization interface 135 
(ESI) operated in positive-ion mode.  
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Two types of acquisition, MS/MS and MS
E
, were performed. For MS/MS 
experiments, cone voltage and collision energy ramp were optimized for each 
compound individually (Table SI 2). For MS
E
 experiments, two acquisition functions 
with different collision energies were created: the low energy function (LE), and the 140 
high energy (HE) function, with the same compound-dependent optimized cone voltage 
and collision energy ramp as for MS/MS.  
Further details on instrument operating conditions both chromatographic and 
spectrometric can be found elsewhere. 
[12]
 
145 
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3. RESULTS AND DISCUSSION 
 
3.1. General aspects 
Several papers report on MS fragmentation of drugs of abuse. Recently, 
Castiglioni et al. 
[3]
 published an excellent review on fragmentation of several drugs of 150 
abuse and metabolites frequently found in wastewater and surface water, based on 
nominal mass measurements by LC–MS/MS (QqQ). A more detailed investigation of 
the fragmentation should be based on accurate mass data. This would allow the 
elucidation of the chemical formulae of fragments with higher confidence. The 
information obtained would permit a more rational selection of structural specific 155 
fragments, which is of interest for LC–MS analytical methods, e.g. using TOF or QqQ 
mass analyzers, giving a more reliable identification of analytes and minimizing the 
possibility of reporting false positives or false negatives. A reduction of interferences 
and an increase in the signal-to-noise ratio could also be obtained by performing 
extracted ion chromatograms (XIC) from full-spectrum accurate-mass data, selecting 160 
narrow m/z windows (e.g., ± 0.01 Da). 
[28, 29]
 In analyses involving selected reaction 
monitoring (SRM) in a QqQ instrument, the same effect could be expected by selection 
of more specific ions.  
For the present paper, data were acquired in both MS/MS and MS
E
 mode using a 
QTOF instrument in positive-ion ESI. The MS
E
 acquisition strategy was recently 165 
introduced for QTOF instruments 
[12, 30-32]
: a continuous scan-wise switching is made 
between low collision energy, to detect ions from intact molecules, and high collision 
energy, to acquire fragmentation data. This technique enables acquisition of ions from 
parent molecules, their isotopic patterns, and their fragment ions in a single injection. It 
has become a powerful tool for wide-scope screening of a large number of compounds 170 
with strong identification capabilities.  
Although product ion and MS
E
 mass spectra were highly comparable, the 
different characteristics of each mode were useful for the elucidation of certain 
fragments. When applied to samples, e.g. urban wastewater, product ion mass spectra 
are generally cleaner and the sensitivity is higher, as specific precursor ions are selected 175 
in the quadrupole. 
Optimum MS/MS and (HE) MS
E
 conditions for each compound were 
established and are listed in Table SI 2 of Supporting Information (SI). Data 
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interpretation was based on accurate m/z values observed for the fragment ions, often 
both of the drugs and of a deuterated analogue, the molecular formulae derived from the 180 
measured accurate m/z, and the general concept that fragmentation should involve 
logical neutral losses and no major rearrangements in the structure of the drug. Based on 
these concepts, structures for the fragment ions have been proposed. No attempts were 
made to prove the proposed structures by further experiments or theoretical calculations. 
Isotope information from the MS
E
 was also of help. Accurate-mass information allowed 185 
us to confirm the fragment ion identity previously proposed by other authors, e.g. based 
on nominal mass measurements. In addition, accurate-mass data were essential to 
understand the fragmentation and/or to discard structures suggested in the literature.  
 
3.2. Cannabinoids 190 
The most psychoactive cannabinoid is ∆9-tetrahydrocannabinol (THC). The 
amount of THC is used as a measure of “cannabis potency”. But as marker compounds 
of cannabis consumption, the THC metabolite 11-nor-9-carboxy-∆9-THC (THC-
COOH) and its glucuronic-acid conjugate (THC-COOH-glucuronide) is generally 
analyzed by LC–MS/MS in human plasma [18] and in urine samples. [33, 34] In 195 
wastewater, where glucuronide conjugates are easily hydrolyzed to the free acid by 
beta-glucuronidase of fecal bacteria 
[35]
, THC-COOH is the analytical target of choice. 
THC-COOH has been determined by LC–MS/MS both in negative-ion [36, 37] and 
positive-ion mode. 
[38, 39]
 The most abundant fragment ions in the product ion mass 
spectra of the deprotonated and protonated molecule of THC-COOH have been 200 
discussed before. 
[3, 18]
 A structure of a less abundant, but more specific fragment ion, 
with m/z 193, to be (2,6-dihydroxy-4-pentylphenyl)methylium was proposed by 
Maralikova et al. based on triple quadrupole data. 
[18]
  
The proposed fragments of the protonated molecule could be confirmed by our 
accurate-mass data. Additionally, with the help of the product ion mass spectra (Figure 205 
1B and C) of the protonated THC-COOH ion and THC-COOH-d3 deuterated analogue, 
several less abundant fragment ions, not reported previously, could be identified (Figure 
1A). As the D3C group is at the end of the pentyl chain, any +3 shift between the m/z 
values in the product ion mass spectra of the [M+H]
+
 ion of THC-COOH and its 
deuterated analogue indicates the pentyl chain is unaffected by the fragmentation. This 210 
is true for the m/z 193 fragment ion, but also for m/z 257, corresponding to the loss of 
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propene (C3H6) from the fragment ion m/z 299 [M+H–HCOOH]
+
, which involves ring 
opening of the saturated six-member ring. On the other hand, the fragment ions with m/z 
229 and 187 do not show the +3 shift, indicating that these fragments originate from the 
loss of pentene (C5H10) and the combined loss of pentene and propene, respectively, 215 
from the fragment ion with m/z 299.  
In the case of THC-COOH, accurate-mass information served as a confirmation 
tool of fragments previously suggested based on nominal mass measurements. 
Comparison of mass spectra of this metabolite and of its deuterated analogue was 
essential for the identification of less abundant fragments and understanding the 220 
fragmentation route. 
   
3.3. Ketamine 
In the aqueous environment, detection of ketamine in wastewater has been 
reported a few times. 
[40, 41]
 Ketamine is a licit pharmaceutical, and as such, has some 225 
abuse potential and is connected to the “club drug” scene. [42] 
As shown in prior work by the authors, the MS
E
 spectrum of the [M+H]
+
 ion and 
fragment ions of ketamine showed useful isotopic information related to the presence of 
one chlorine atom. 
[40]
 This information together with the accurate mass of both 
precursor and fragment ions confirmed the fragmentation proposed by Wang et al. 
[19]
 230 
with high confidence. The chlorine atom is still present in all fragments, with the 
exception of those with m/z 115 and 116. Most of them can be explained being due to 
the sequence of losses of water and methylamine (in either order) to the ion m/z 189, 
with intermediate ions m/z 220 and 207, respectively, and further fragmentation to ions 
m/z 179 (CO loss from the ion with m/z 207) and m/z 125. Most likely, the (2-235 
chlorophenyl)methylium ion with m/z 125 is more readily formed from the ion m/z 179, 
due to an inductive cleavage involving the loss of C4H6, because the alternative route 
from m/z 189 requires the cleavage of two C-C bonds, which seems less likely (Figure 
SI 1). 
The ions with m/z 115 and 116 (C9H7
+
 and C9H8
+•
, respectively)
 
involve the loss 240 
of chlorine, either as HCl or as a radical. From the ketamine-d4 spectrum (Figure SI 
1B), one may conclude that this may be a Cl-radical, HCl or DCl. However, the 
pathway involved in the loss of chlorine is certainly not evident, because for instance an 
ion with m/z 151/153 is not clearly observed. 
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The fragmentation of ketamine derivatized heptafluorobutyric anhydride has 245 
been studied by Pieri et al. 
[17]
 using GC–MS and electron ionization. Obviously, a 
fragmentation pathway of the derivatized ketamine under these conditions significantly 
differs from that reported here. 
 
3.4. Amphetamine and amphetamine-type stimulants 250 
Since Jones-Lepp et al. reported methamphetamine and MDMA in effluent 
wastewater in the USA 
[43]
, amphetamine and amphetamine-type stimulants (ATS) have 
frequently been detected at ng/L level in influent wastewater and sometimes in effluent 
samples. 
[38, 41, 44 - 46]
 ATS are a group of synthetic stimulants, including predominantly 
amphetamine, methamphetamine, MDA, MDMA (ecstasy) and MDEA. Amphetamine 255 
analogues, such as methcathinone, may also be included in this group. Furthermore, the 
most commonly used ATS chemical precursors such as ephedrine fall under 
international control, and their seizure can provide some limited indications about 
manufacturer trends. 
[42]
  
The MS/MS fragmentation patterns of the [M+H]
+
 ion of amphetamine (Figure 260 
2A) and methamphetamine are straightforward with the fragment ion m/z 119, resulting 
from the loss of ammonia or methylamine, respectively, the tropylium ion (C7H7
+
 with 
m/z 91) due to a β-C-C cleavage, and the secondary fragment m/z 65 (C5H5
+
) due to the 
loss of acetylene from the ion m/z 91, as common fragment ions. The product ion mass 
spectrum of amphetamine-d6 leads to some interesting novel observations (Figure 2B). 265 
Given the deuterium positions in the amphetamine-d6 (C6H5–CD2–CD(–NH2)–CD3), a 
straightforward β-C-C cleavage would lead to a tropylium ion with the formula C7H5D2
+
 
(m/z 93). However, next to the ion with m/z 93, two other ions were observed consistent 
with m/z 94 (C7H4D3
+
) and m/z 95 (C7H3D4
+
), which indicate scrambling of the labels 
during fragmentation (Figure 2C). NMR spectroscopy was applied to confirm the 270 
specified positions of the D-labels. In turn, the ions m/z 93, 94 and 95 provide 
secondary fragmentation involving the loss of either HCCH, HCCD, or DCCD, leading 
to fragment ions with m/z 65 (C5H5
+
), 66 (C5H4D
+
), 67 (C5H3D2
+
), 68 (C5H2D3
+
) and 69 
(C5HD4
+
) (Figure 2D). Essentially the same results were obtained by collision-cell 
fragmentation of the precursor ions m/z 93, 94 and 95, generated by in-source 275 
fragmentation of amphetamine-d6. In our opinion, these observations are most readily 
explained if the fragment ion m/z 91 has a tropylium ion and not a benzyl cation 
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structure. Moreover, it puts some light on the complexity of the fragmentation 
mechanism of a protonated molecule, as the β-C-C cleavage apparently involves 
scrambling of ring and chain hydrogen atoms. Further complexity is added by the 280 
product ion mass spectrum of methamphetamine-d5, where next to the most abundant 
ion m/z 92 (C7H6D
+
), consistent with a straightforward β-C-C cleavage, the ions m/z 91 
(one D-label lost, C7H7
+
) and m/z 93 (one D-label gained, C7H5D2
+
) are also observed. 
Similar secondary fragmentation was obtained, involving losses of HCCH, HCCD, and 
DCCD.  285 
Compared to other amphetamine analogues, methcathinone and ephedrine have 
been scarcely studied. To the best of our knowledge, a detailed study on their 
fragmentation pathway has not been reported. The structures of these compounds are 
comparable to methamphetamine, yet with either a ketone- or hydroxyl-group at the C
1
 
position, respectively. This significantly affects the fragmentation. Methcathinone 290 
([M+H]
+
 with m/z 164) (Figure 3A) and ephedrine ([M+H]
+
 with m/z 166) (Figure 3B) 
both show the loss of water with remarkable ease from the keto- or hydroxyl-function, 
respectively, and subsequently the loss of CH3
•
, resulting in the radical cations m/z 131 
and m/z 133, respectively. To this end, there are two methyl-groups that could be lost: 
N-CH3 and C
2
-CH3. From the ephedrine-d3 spectrum (Figure 3C), one can deduce, that 295 
both losses actually occur, with the loss from C
2
-CH3 resulting in a more abundant 
fragment (m/z 136) than the loss from N-CH3. The loss of CH4 is also observed, leading 
to fragments with m/z 130 and 132 of the unlabeled compounds, respectively. Structures 
for these fragment ions are proposed in Figure 3. At low m/z, the spectra differ 
considerably (Figure 3A and B). Methcathinone shows a fragment with m/z 105.0699. 300 
Accurate-mass data (Figure 3A) prove that this ion corresponds to C6H5–C
+
H–CH3 
(calculated m/z 105.0704, mass error 0.5 mDa) rather than the expected C6H5–C≡O
+
 
(calculated m/z 105.0340, mass error 35.9 mDa). Ephedrine, on the other hand, shows a 
fragment with m/z 117, owing to subsequent losses of water and methylamine, as well 
as a fragment with m/z 115, which can be written as a stable ring structure with a 305 
resonance-delocalized charge, after an apparently easy loss of H2 from the ion with m/z 
117.  
MDA, MDMA and MDEA, containing a dioxole ring, all give similar 
fragmentation patterns, with the exception of some minor fragments at the lower end of 
the spectra and, obviously, the protonated molecule. As an example, MDA ([M+H]
+
 310 
with m/z 180) (Figure 4A) shows a loss of NH3 to a fragment ion with m/z 163 and a β-
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C-C cleavage leading to a 1,3-benzodioxol-5-ylmethylium ion with m/z 135 due to the 
loss of ethylamine. Structure of these and some other fragment ions are proposed in 
Figure 4. This pattern is similar to what is observed for amphetamine and related 
compounds, as described above. With MDMA and MDEA, the same β-C-C cleavage 315 
also leads to minor immonium ions with m/z 58 and 72, consistent with the loss of 5-
methyl-1,3-benzodioxole from [M+H]
+
. The fragment ion with m/z 133 can be 
considered as a secondary fragment of the ion with m/z 163 (after loss of ammonia) and 
corresponds to a loss of H2C=O due to cleavage of the methylenedioxy ring. An 
interesting fragment is the ion with m/z 105, since this ion has been interpreted as being 320 
due to the loss of H2C=O from the ion with m/z 135 (thus with formula C7H5O
+
, 
calculated m/z 105.0340) 
[3]
, whereas our accurate-mass data (m/z 105.0703) suggests 
that the correct formula is C8H9
+
 (calculated m/z 105.0704, mass error 0.1 mDa). 
Structures of both C7H5O
+
 and C8H9
+
 are shown in Figure 4. In addition, data of its 
labeled analogue (Figure 4B) proofs this interpretation of m/z 105.0704 to be correct, as 325 
it would be the only way to account for five labels in this fragment.  
Study of the labeled analogues of MDA, MDMA and MDEA was consistent 
with our expectation. Some H/D scrambling was observed, similar to the observations 
of the labeled analogues of (meth)amphetamine. No H/D scrambling was observed in 
the spectra of MDEA-d5, where D-labeling is at the N-ethyl group. 330 
 
3.5. Cocaine 
Cocaine and its metabolites are frequently reported to be found in the aquatic 
environment. Concentrations are relatively high (sometimes up to µg/L level), 
especially for its major metabolite benzoylecgonine, compared to other illicit drugs. 
[41, 
335 
44, 45]
   
By using product ion mass spectra of labeled and unlabeled compounds, Wang 
et al. 
[20]
 comprehensively described fragmentation pathways for cocaine, its metabolites 
and pyrolytic degradation products. Later, Castiglioni et al. 
[3]
 also reported 
fragmentation data on this group of compounds, supporting them with the 340 
corresponding mass spectra. The fragmentation mechanisms proposed by these authors 
are confirmed by our accurate-mass spectra (data not shown). The most abundant 
fragment of cocaine and most of its metabolites can be assigned to the neutral loss of 
benzoic acid (122 Da). The remaining fragment ions can be considered as subsequent 
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fragmentation of the resulting ion [M+H – 122]+, involving a further loss of methanol or 345 
water.   
 
3.6. Opiates 
As they are frequently used as narcotic to relief pain, opiates can enter the 
environment not only by way of drug abuse but also due to clinical usage. The opiates 350 
most widely used as abusive drug are heroin, morphine and codeine. These compounds 
have been found (few ng/L) in wastewater, together with their related metabolites, 6-
monoacetylmorphine (6-MAM) and norcodeine. 
[36, 37, 39]
 Glucuronide conjugates such 
as morphine-3-β-glucuronide or morphine-6-β-glucuronide have also been found in 
sewage water. 
[36]
 Fragmentation of these conjugates shows an intense fragment ion 355 
corresponding to the characteristic loss of the dehydroglucuronic acid group (loss of 
176 Da). 
[3]
 Here, only the fragmentation of unconjugated opiates was studied. 
The structures of the opiates and their deuterated analogues studied in this work 
are illustrated in the supporting information (Table SI 1). And, in addition to the 
mentioned references, visual assistance is available to the reader (Figure SI 2) to get 360 
more insight in the proposed fragmentation route of opiates. Fragmentation pathways at 
the high end of the spectra have been studied by other authors 
[23-25]
 and our accurate-
mass data confirm the earlier interpretation. However, fragment ions at the lower end of 
the spectra have generally been ignored.  
The loss of the ketene H2C=C=O and acetic acid (from heroin), acetic acid (from 365 
6-MAM) and water (from morphine) in all three cases results in a fragment ion at m/z 
268 (C17H18NO2
+
) (see Figure SI 2). Subsequent fragmentation involves cleavages in 
the morphinan backbone. This results in complex fragmentation patterns, in which 
heroin, 6-MAM and morphine, but also nor-morphine, codeine and nor-codeine, show 
many similar features. 370 
Taking heroin as an example (Figure 5A), an initial cleavage of the piperidine 
ring occurs. The most abundant fragment results from the loss of H3C–CH2=N–CH3 (57 
Da) to fragment ion with m/z 211 (C14H11O2
+
), although fragment ions due to the loss of 
H2C=N–CH3 (43 Da) to m/z 225 (C15H13O2
+
) and H2N–CH3 (31 Da) to m/z 237 
(C16H13O2
+
) are also observed. The structure proposed by Zhang et al. 
[25]
 for the ion 375 
with m/z 225, involving a seven-member ring, seems unlikely, as it would require 
significant rearrangement of the structure; an alternative proposal is given in Figure 5 
(top).  
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Next to the ion with m/z 211, an ion with m/z 209 (C14H9O2
+
) is observed, which 
would involve an additional double bond in the remaining structure with four fused 380 
rings. Similar behavior is observed for the fragment ions with m/z 193 (C14H9O
+
) and 
183 (C13H11O
+
), which are due to losses of water or CO, respectively, from the ion with 
m/z 211; thus ions with m/z 191 (C14H7O
+
) and 181 (C13H9O
+
) are observed as well (see 
Figure SI 2). The lower m/z satellite peaks (m/z 191 and 181) show greater aromaticity, 
which may be the driving force in their formation.  385 
Careful comparison of the spectra of heroin and heroin-d9 reveals that the loss of 
water to give m/z 193 from ion with m/z 211 (Figure 5A) involves either the oxygen 
from 4,5-epoxide or the 3-hydroxy group, whereas the loss of CO mainly appears to 
involve the oxygen from 4,5-epoxide. It should be pointed out that in the heroin-d9 
spectrum the loss of water from m/z 212 would lead to both fragment ions with m/z 193 390 
and m/z 194 (Figure 5B). This is only possible if the loss of water involves the oxygen 
of either of the two groups, with the loss of the hydroxy-O (as HDO) leading to m/z 193 
and the loss of the epoxy-O (as H2O) to m/z 194. In heroin-d9, the three methyl groups 
of heroin are CD3 groups. In the fragment ion with m/z 212, two CD3 groups have been 
lost with the loss of acetic acid and the N–CD3 substituent; one D-label is still present, 395 
resulting from D-rearrangement upon the loss of the ketene D2C=C=O.  
Regarding the CO loss, only the fragment ion m/z 184 is observed in the heroin-
d9 spectrum, but not the m/z 183 (Figure 5B), suggesting that only 4,5-epoxide is 
involved in this loss, maintaining the 3-hydroxy group. Moreover, an abundant 
fragment (m/z 182) was also observed, due to H2 loss. This demonstrates that D-400 
labeling of heroin and related compounds was important in elucidation of the 
fragmentation pathway. From our point of view, the structure suggested by others for 
the fragment ion m/z 181 of heroin and related compounds, with a 4-hydroxy group, is 
unlikely. 
[24, 25]
 We think that the 3-hydroxy group is more appropriate (Figure 5 (top)).     
An abundant fragment in the spectra of opiates is the ion m/z 165. It is frequently 405 
selected in SRM analysis for quantification or confirmation of opiates in wastewater. 
[37, 
39]
 The ion m/z 165/166 can be derived from the ion m/z 193/194 due to the loss of CO 
or from the ion m/z 183/184 due to the loss of water.  
It is noteworthy that the fragment ions involving additional loss of H2 and thus 
the formation of a double bond (m/z 191, 181 and also 153, see below) as well as the 410 
most abundant ion in the quadrupole spectra (m/z 165) were not observed in ion-trap 
MS
2
 spectra, but only as minor ions in subsequent MS
3
 and MS
4
 spectra. 
[23, 25]
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Fragment ions at the lower end of the spectra have been generally ignored. The 
formation of ions such as m/z 157, 141, and 115 is complex and involves multiple 
neutral losses and/or losses of larger neutral fragments (Figure 5A). Structure 415 
elucidation is complicated and unambiguous structures cannot always be proposed. At 
this point, it was helpful to perform additional experiments using a triple-quadrupole 
MS/MS instrument. By performing precursor-ion scans of the more abundant low-m/z 
fragment ions, more insight was obtained in their fragmentation pathways.  
The precursor ions of the morphine product ion with m/z 157 (C11H9O
+
) are the 420 
m/z 185, 201 and 229 ions, involving neutral losses of CO, H3C-CH=O and CO + H3C-
CH=O, respectively. We compared these data with the precursor-ion scan data of the 
related product ion of codeine, i.e., m/z 171. Codeine contains a methoxy- instead of a 
hydroxy-group on the C
3
 position resulting in a mass shift of +14 in the m/z value of 
various product ions relative to morphine. Furthermore, the deuterated analogue of 425 
codeine (codeine-d6) contains three additional D-labels on this methoxy-group 
compared to morphine-d3. Thus, the corresponding codeine fragment ion with m/z 171 
results from precursors m/z 199, 215 and 243; the mass shift of 14 Da indicates an 
identical fragmentation pathway in which the methoxy-group is kept. 
Based on these results, possible fragmentation pathways for the low-m/z 430 
fragments are discussed in more detail starting from the product ions with m/z 243 and 
229 of codeine and morphine, respectively, formed by the complete loss of the 
piperidine ring (see Figure SI 2).  
The formation and structure of fragment ions m/z 141 (C11H9
+
) and m/z 115 
(C9H7
+
) are less evident. Results from precursor-ion scans for m/z 141, showed the 435 
presence of m/z 201 and 229 for morphine, and with m/z 215 and 243 for codeine, 
pointing out an identical fragmentation route, retaining the oxygen-group at the C
3
 
position. A key-role can be attributed to the precursor ions m/z 201 (morphine) and m/z 
215 (codeine), which can be formed by the loss of CO from the m/z 229 and m/z 243 
ions, respectively. However, the loss of CO can be associated with the oxygen either 440 
from the 4,5-epoxide or the 6-hydroxy group. In Figure 6 (top), three possible structures 
for fragment ion m/z 201 (and m/z 215) are proposed: A and B involving the loss of 6-
hydroxy oxygen, whereas C involves the loss of 4,5-epoxide group. Structures A and B 
are convincing to explain the formation of the ion m/z 141 from the precursor ion m/z 
201 (or m/z 215). It appears to correspond to a one-step loss of HC(=O)-CH2OH for 445 
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morphine and of HC(=O)-CH2OCH3 for codeine. Structure C is unlikely to be involved 
in the formation of m/z 141.  
Regarding fragment ion m/z 115, the precursor ion with m/z 201 (and m/z 215 
for codeine) possibly also plays an important role in the formation of this fragment, 
although in this case an intermediate ion, m/z 173 (and m/z 187 for codeine) is also 450 
participating in the fragmentation pathway based on precursor ion scan data. According 
to the high-resolution accurate-mass data (Figure 6 (bottom)), two isobaric fragment 
ions with m/z 173 (C11H9O2
+
 or C12H13O
+
) are formed. Zhang et al. proposed two 
different structures for this fragment ion, involving a one-step or two-step fragmentation 
from m/z 229. Our TOF MS data clearly shows the presence of both these fragment 455 
ions, m/z 173.0609 and m/z 173.0981, demonstrating that both pathways are surely 
involved. However, we believe that fragment ions are formed only from the precursor 
ion m/z 201, involving a one-step loss of either C2H4 from structure 6A (supported by 
the presence of m/z 173.0609) or a loss of CO from structure 6 C (supported by m/z 
173.0981). 460 
In both cases, a further one-step fragmentation to m/z 115 is complicated, 
implying less logic rearrangements and fragmentation of aromatic rings. Identical 
complicated one-step fragmentation is involved in the formation of m/z 115 from the 
codeine intermediate ions m/z 187 (C13H15O
+
 or C12H11O2
+
). Therefore, unequivocal 
structure for the fragment ion with m/z 115 could not be suggested. 465 
 
3.7. Applied issues  
LC–QTOF MS is a powerful technique for identification and confirmation 
purposes, very attractive for wide-scope screening of drugs of abuse in the environment. 
To take full profit of its qualitative and elucidative potential, a detailed knowledge of 470 
the fragmentation pathways is required. The possibility of searching for drug-related 
compounds is one of the strong points of TOF MS. Assuming that most of these 
compounds share similar fragmentation pathway with the parent drug, the knowledge of 
fragment ions of the main drugs of abuse is essential to search for metabolites, 
transformation and/or degradation products. Different approaches can be applied based 475 
on accurate-mass measurements of common fragment ions. Nowadays, manufacturers 
provide automated software algorithms to detect expected and unexpected metabolites. 
Most of these algorithms are designed to compare and contrast chromatograms of a 
presumptive positive sample with a control or blank sample. However, in environmental 
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analysis, a representative blank sample is practically impossible to obtain, and this 480 
approach seems less useful. An alternative way is to obtain narrow-mass window 
extracted ion chromatograms (e.g., ± 0.01 Da) for specific fragment ions from the HE 
and/or LE functions of MS
E
 data. When these chromatograms show additional 
chromatographic peaks at retention times different to that of the parent drug, the 
presence of parent-chemically related compounds can reasonably be expected in the 485 
sample. This approach, based on assuming similar fragmentation pathways for parent 
analyte and their metabolites has successfully been applied for investigation of pesticide 
metabolites. 
[47]
 Another example illustrating the relevance of knowing the 
fragmentation in detail is the possibility to differentiate isomers from their specific 
fragments, as although sharing the same empirical formula and exact mass they can 490 
suffer different fragmentation. 
[12, 40]
 
The selection of specific fragment ions is not only relevant when searching for 
metabolites  or transformation products using accurate-mass data, but also for the 
selection of appropriate (selective) SRM transitions in quantitative analyses using QqQ 
instruments. As pointed out by Pozo et al. 
[48]
, non-specific transitions such as those 495 
involving the loss of water or CO may result in reporting false positives or false 
negatives, as the probability of finding interferences sharing the same transition 
increases. This is more likely to occur when dealing with analytes at sub-ppb levels in 
complex matrices, e.g., the determination of drugs of abuse in urban wastewater. In 
addition, the most sensitive transitions (typically selected in quantitative methods) not 500 
necessarily are the most selective ones. Therefore, the selection of fragment ions taking 
into account not only their abundance but also their specificity is of great relevance for 
trace-level analysis. The European Union established the acquisition of at least two 
SRM transitions in low-resolution MS instruments, together with the measurement of 
their intensity ratio for confirmation of contaminants in samples of animal origin.
[49]
 505 
This criterion is also frequently used in the determination of organic contaminants in 
environmental samples. However, no requirements are given on the selectivity/ 
specificity of the selected ions. In our opinion, more attention needs to be paid to the 
specificity of the (fragment) ions in order to minimize the possibility of reporting false 
positives, especially when legal or societal implications are involved. An interference 510 
sharing one of the transitions may lead to report the sample as negative because of the 
non-compliance of the Q/q ratio, even in cases where the analyte is present. In any case, 
the maximum tolerances established for Q/q ratio deviations are subject of controversy, 
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especially in complex-matrix samples. 
[48, 50]
 Unfortunately, information on Q/q ratio 
values in samples and reference standards is not always given in the literature. A 515 
detailed knowledge of fragmentation pathways and the expertise of the researcher on 
MS are among other aspects of great importance to obtain reliable data in LC/MS based 
methods. 
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4. CONCLUSIONS 520 
 
Accurate-mass spectral data for some classes of illicit drugs and their related 
substances (metabolites, degradation products), that are frequently detected in 
environmental and wastewaters, have been obtained using QTOF MS in both MS/MS 
and MS
E
 mode. Based on these data, fragmentation pathways have been carefully 525 
elucidated. Although nominal-mass measurement can already be useful for elucidation 
purposes in many cases, accurate-mass information is imperative for confirmation of the 
identity of such fragment ions as well as to allow elucidation of structures of several 
important key ions. In some cases, accurate-mass data of deuterated analogues also 
played a key role in the elucidation of the fragmentation. All information provided by 530 
QTOF MS helped us to elucidate structures with high reliability and to complete 
fragmentation pathways.  
The information in this paper can help the reader to interpret related spectra and 
to select specific fragments for the safe identification of these emerging contaminants in 
environmental, food or biological sample matrices. 535 
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SUPPORTING INFORMATION 
In this section, a table with useful information for 37 drugs of abuse, their 
metabolites and deuterated analogues investigated is shown (Table SI 1). Chemical 
structures, exact masses of the protonated molecules and CAS numbers are given. In 
addition, a table with optimum MS/MS and MS
E
 conditions used for the interpretation 550 
of these compounds are also given (Table SI 2).  Furthermore two figures, one reporting 
fragmentation pathway of ketamine and MS
E
 (HE) spectra of the [M+H]
+
 ion of both 
ketamine and its deuterated analogue (Figure SI 1), and another including a 
fragmentation route of opiates via morphinan backbone (Figure SI 2), are added to have 
supportive visual information on the written text.   555 
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 735 
 FIGURE CAPTIONS 
 
Figure 1. Structure proposals for some THC-COOH fragment ions (A), product ion (QTOF) mass spectra of [M+H]
+
 of THC-COOH (B) and 
THC-COOH-d3 (C).  
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Figure 2. Product ion (QTOF) mass spectra of [M+H]
+
 of amphetamine (A) and amphetamine-d6 (B) (range m/z 60-70, 82x magnified), H/D 
scrambling of the tropylium ion (C) and the secondary fragments of the tropylium ion (D) of amphetamine-d6. 
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Figure 3. Structure proposals for some of the fragment ions in the product ion mass spectra of [M+H]
+
 of methcathinone (left) and ephedrine 
(right). MS
E
 (HE) spectra (middle) of methcathinone (A), ephedrine (B) and ephedrine-d3 (C). 745 
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Figure 4. Structure proposals for some of the fragment ions of [M+H]
+
 of MDA. MS
E
 (HE) spectra (right) of MDA (A), MDA-d5 (B): Insert, 
structure of MDA deuterated fragment m/z 110.  
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Figure 5. Product ion mass spectra of [M+H]
+
 of heroin (A) and heroin-d9 (B) (bottom) with zoom in the range m/z 175-215. Proposed structures 
for product ions m/z 181 (C13H9O
+
) and m/z 225 (C15H13O2
+
), involving cleavage in the morphinan backbone (top). 
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Figure 6. Product ion mass spectrum of [M+H]
+
 of morphine and three possible chemical structures (A, B, C) suggested for morphine fragment 
m/z 201.0915 (R=H, C13H13O2
+
) and codeine fragment m/z 215.0915 (R=CH3, C14H15O2
+
). The loss of HC(=O)-CH2OR to m/z 
141.0704 is illustrated as a dotted line (top). 760 
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Supporting information 
 765 
 
 
Table SI 1: Chemical structure, exact mass of the protonated molecule, and CAS 
number of the selected illicit drugs and their deuterated analogues. 
 770 
Structure Compound 
Exact mass [M+H]+ 
CAS number 
Structure Compound 
Exact mass [M+H]+ 
CAS number 
N
H3C
O
CH3
O
O
O
 
Cocaine 
304.1549 
[50-36-2] 
N
CD3
O
CH3
O
O
O
 
Cocaine-d3 
307.1737 
[65266-73-1] 
N
H3C
O
O
O
O
CH3
 
Cocaethylene 
318.1705 
[529-38-4] 
N
CD3
O
D2
C
O
O
O
CD3
 
Cocaethylene-d8 
326.2207 
[152521-09-0] 
N
H3C
OH
O
O
O
 
Benzoylecgonine 
290.1392 
[519-09-5] 
N
CD3
OH
O
O
O
 
Benzoylecgonine-
d3 
293.1580 
[115732-68-8] 
N
H3C
OH
OH
O
 
Ecgonine 
186.1130 
[5796-31-6] 
N
CD3
OH
OH
O
 
Ecgonine-d3 
189.1318 
[N/A] 
N
H
O
CH3
O
O
O
 
Norcocaine 
290.1392 
[61585-22-6] 
  
N
H
OH
O
O
O
 
Norbenzoylecgonine 
276.1236 
[60426-41-7] 
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Structure Compound 
Exact mass [M+H]+ 
CAS number 
Structure Compound 
Exact mass [M+H]+ 
CAS number 
CH3
NH2
 
Amphetamine 
136.1126 
[300-62-9] 
D2
C
D
C
CD3
NH2
 
Amphetamine-d6 
142.1503 
[N/A] 
CH3
HN
CH3 
Methamphetamine 
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DH
C
D
C
CH3
HN
CD3 
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d5 
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[60124-88-1] 
CH3
NH2
O
O  
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DH
C
D
C
CD3
NH2
O
O  
MDA-d5 
185.1338 
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CH3
NH
O
O CH3 
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DH
C
D
C
CH3
NH
O
O CD3 
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CH3
HN
O
O
CH3
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CH3
HN
O
O
C
D2
CD3
 
MDEA-d5 
213.1651 
[160227-43-0] 
OH
CH3
H
N
CH3
 
Ephedrine 
166.1232 
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OH
CH3
H
N
CD3
 
Ephedrine-d3 
169.1420 
[N/A] 
O
HN
CH3
CH3
 
Methcathinone 
164.1075 
[152610-69-0] 
  
Cl
NH
CH3
O
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238.0998 
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DC
DC
CD
D
C
Cl
NH
CH3
O
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Structure Compound 
Exact mass 
[M+H]+ 
CAS number 
Structure Compound 
Exact mass 
[M+H]+ 
CAS number 
O
O
CH3
N
O
O
H3C
O
H3C
 
Heroin 
370.1654 
[561-27-3] 
O
O
CD3
N
O
O
D3C
O
D3C
 
Heroin-d9 
379.2219 
[N/A] 
O
HO
CH3
N
O
O
H3C
 
6-MAM 
328.1549 
[2784-73-8] 
O
HO
CD3
N
O
O
D3C
 
6-MAM-d6 
334.1925 
[152477-90-2] 
O
HO
CH3
N
HO  
Morphine 
286.1443 
[57-27-2] 
O
HO
CD3
N
HO  
Morphine-d3 
289.1631 
[67293-88-3] 
O
O
H3C
CH3
N
OH  
Codeine 
300.1599 
[76-57-3] 
O
O
D3C
CD3
N
OH  
Codeine-d6 
306.1976 
[N/A] 
O
HO
NH
HO  
Normorphine 
272.1286 
[466-97-7] 
 
  
O
O
H3C
NH
OH  
Norcodeine 
286.1443 
[467-15-2] 
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Table SI 2: Optimum MS/MS 
(a)
 and MS
E (b)
 conditions used for the interpretation of 
spectra of illicit drugs and their metabolites. (ESI operated in positive ionization mode) 
 
Compound 
 
Retention time  
(min) 
Cone voltage 
(V) 
High Collision  
Energy (eV) 
THC-COOH 8.77 25 10-45 
THC-COOH-d3 8.77 25 10-40 
Ketamine 3.76 15 10-40 
Ketamine-d4 3.74 10 10-40 
Amphetamine 3.05 10 10-50 
Amphetamine-d6 3.03 10 10-40 
MDA 3.08 10 10-45 
MDA-d5 3.03 10 10-40 
MDEA 3.43 15 10-40 
MDEA-d5 3.42 15 10-45 
MDMA 3.12 10 10-40 
MDMA-d5 3.11 10 10-45 
Methamphetamine 3.15 15 10-40 
Methamphetamine-d5 3.12 15 10-45 
Benzoylecgonine 3.78 15 10-40 
Benzoylecgonine-d3 3.78 15 10-40 
Cocaethylene 4.67 20 10-40 
Cocaethylene-d8 4.66 20 10-40 
Cocaine 4.10 15 10-40 
Cocaine-d3 4.10 20 10-40 
Ecgonine 1.00 20 10-50 
Ecgonine-d3 0.99 20 10-45 
Norbenzoylecgonine 3.92 15 10-45 
Norcocaine 4.37 15 10-40 
6-Acetylmorphine 2.83 25 20-60 
6-Acetylmorphine-d6 2.79 25 20-50 
Codeine 2.45 20 20-60 
Codeine-d6 2.46 25 20-50 
Ephedrine 2.66 10 10-45 
Ephedrine-d3 2.64 10 10-40 
Heroin 3.97 30 20-60 
Heroin-d9 3.95 35 20-50 
Methcathinone 2.64 15 10-40 
Morphine 1.64 30 20-50 
Morphine-d3 1.62 35 20-50 
Norcodeine 2.55 25 20-50 
Normorphine 1.54 25 20-50 
a) MS/MS conditions, selecting the protonated molecule [M+H]+ as precursor ion. 
b) Conditions used for MSE in the HE mode. The collision energy applied in the LE 785 
mode was in all cases 4eV. 
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FIGURE CAPTIONS 790 
 
Figure SI 1. Proposed ketamine fragmentation pathway (left). MS
E
 (HE) spectra (right) 
of [M+H]
+
 of ketamine (A), ketamine-d4 (B).  
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Figure SI 2. Proposed fragmentation route of opiates via morphinan backbone. 
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